Provides an ESC task force consensus on the necessary clinical investigations and translational challenges for using autologous adult stem cells in heart repair.
Should not yet change clinical practice for heart repair; specifies the studies needed to overcome translational barriers.
A task force has been established by the European Society of Cardiology to investigate the role of progenitor/stem cell therapy in the treatment of cardiovascular disease. This article is the consensus of this group, of what clinical studies are needed in this field, and the challenges to be addressed in the translation of progenitor/stem cell biology to repair of the heart.
No takes yet. Share an insight, caveat, or question.
Bartúnek et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: